177 related articles for article (PubMed ID: 448289)
1. The influence of steroid hormone metabolites on the in vitro development of erythroid colonies derived from human bone marrow.
Urabe A; Sassa S; Kappas A
J Exp Med; 1979 Jun; 149(6):1314-25. PubMed ID: 448289
[TBL] [Abstract][Full Text] [Related]
2. Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: structure/activity relationships.
Singer JW; Samuels AI; Adamson JW
J Cell Physiol; 1976 Jun; 88(2):127-34. PubMed ID: 1270518
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
Malgor LA; Valsecia M; Vergés E; De Markowsky EE
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
[TBL] [Abstract][Full Text] [Related]
4. In vitro steroid sensitivity testing: a possible means to predict response to therapy in primary hypoproliferative anemia.
Dainiak N; Hoffman R; Ritchey AK; Floyd V; Callahan M
Am J Hematol; 1980; 9(4):401-12. PubMed ID: 7211834
[TBL] [Abstract][Full Text] [Related]
5. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
Mangan KF; D'Alessandro L; Mullaney MT
J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
[TBL] [Abstract][Full Text] [Related]
6. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic activity of steroid metabolites in mice.
Gorshein D; Gardner FH
Proc Natl Acad Sci U S A; 1970 Mar; 65(3):564-8. PubMed ID: 4392763
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
[TBL] [Abstract][Full Text] [Related]
9. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
Mitjavila MT; Natazawa M; Brignaschi P; Debili N; Breton-Gorius J; Vainchenker W
J Cell Physiol; 1989 Mar; 138(3):617-23. PubMed ID: 2647773
[TBL] [Abstract][Full Text] [Related]
10. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1996 Feb; 166(2):305-10. PubMed ID: 8591990
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of human early and late erythropoietic progenitor cells by insulin: evidence for different mechanisms.
Konwalinka G; Wiedermann CJ; Petzer A; Grunewald K; Breier C; Patsch J; Geissler D
Adv Exp Med Biol; 1988; 241():273-80. PubMed ID: 3066164
[TBL] [Abstract][Full Text] [Related]
12. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
14. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
15. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
Mamus SW; Oken MM; Zanjani ED
Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
[TBL] [Abstract][Full Text] [Related]
16. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
[TBL] [Abstract][Full Text] [Related]
17. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
[TBL] [Abstract][Full Text] [Related]
18. Increased erythropoietin sensitivity of murine CFU-E and BFU-E in in vivo cultures.
Greenberg HM; Robinson SH
J Lab Clin Med; 1980 May; 95(5):706-13. PubMed ID: 6988531
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
20. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
Feldman L; Frazier JG; Sytkowski AJ
Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
